Newbridge Financial Services Group’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.3K Hold
20,250
– – ﹤0.01% 629
2026
Q2
$42.3K Buy
20,250
+3,250
+19% +$6.4K 0.01% 527
2026
Q1
$29.8K Buy
17,000
+2,000
+13% +$3.64K ﹤0.01% 554
2025
Q4
$35.2K Buy
15,000
+2,000
+15% +$3.84K 0.01% 509
2025
Q3
$11.2K Buy
13,000
+2,500
+24% +$1.95K ﹤0.01% 873
2025
Q2
$7.14K Buy
+10,500
New +$7.52K ﹤0.01% 960

Other funds holding PALI

Newbridge Financial Services Group's PALI Position: Q3 2026 in Review

Newbridge Financial Services Group held its Palisade Bio (PALI) position steady in Q3 2026 at 20,250 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #629.

Newbridge Financial Services Group first reported a position in PALI in Q2 2025 and has held it in 6 quarters since. The position peaked at $42.3K in Q2 2026. 115 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • Newbridge Financial Services Group held 20,250 shares of Palisade Bio worth $27.3K as of Q3 2026.
  • Newbridge Financial Services Group left its Palisade Bio share count unchanged in Q3 2026.
  • Palisade Bio made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q3 2026, its #629 holding.
  • Newbridge Financial Services Group first reported a position in Palisade Bio in Q2 2025 and has held it in 6 quarters since.
  • Newbridge Financial Services Group's Palisade Bio position peaked at $42.3K in Q2 2026.
  • 115 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on Newbridge Financial Services Group's 13F filing for Q3 2026, filed 15 Oct 2026.